A friend of mine bought Emotiv SDK(the one with 16 electrodes) and mentioned that they are being extremely protective/restrictive on what you can do with the de

A friend of mine bought Emotiv SDK(the one with 16 electrodes) and mentioned that they are being extremely protective/restrictive on what you can do with the device (he also said it is very promising but the technology still needs a lot of work). What I suspect is that the device, if it could reach real mass-production, would be very inexpensive to make, thus they are putting in all kind of pitfalls to prospective competitors. Not that one can blame them for being so protective, but it could backfire in the long run, if a nimble competitor open sources most of the software and focuses on hardware or at the very least, makes developers job easier.